From the Research
QR678 is a proprietary hair growth formulation developed for treating hair loss and promoting hair regrowth, composed of a combination of growth factors and peptides, including basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), insulin-like growth factor-1 (IGF-1), keratinocyte growth factor (KGF), and follicle stimulating hormone (FSH), as demonstrated in a study published in the Journal of Cosmetic Dermatology in 2022 1. The formulation is designed to stimulate hair follicles, improve blood circulation to the scalp, and extend the anagen (growth) phase of the hair cycle. Some key points about QR678 include:
- It is typically administered through mesotherapy, involving multiple small injections directly into the scalp at regular intervals, usually once a month for 6-8 sessions initially, followed by maintenance treatments.
- The treatment aims to address various forms of alopecia, including androgenetic alopecia (pattern baldness) and alopecia areata.
- Patients may experience mild discomfort during the procedure, but no significant downtime is required.
- Results typically begin to appear after 2-3 sessions, with reduced hair fall initially followed by new hair growth, as shown in a study published in the Journal of Cosmetic Dermatology in 2020 2. The formulation is designed to be free from harmful preservatives and is claimed to have minimal side effects compared to other hair loss treatments, as demonstrated in a study published in the Journal of Cosmetic Dermatology in 2022 3. In terms of its composition, QR678 includes a combination of growth factors and peptides that work synergistically to promote hair growth, as shown in a study published in Plastic and Reconstructive Surgery-Global Open in 2020 4. Overall, QR678 is a promising treatment option for individuals experiencing hair loss, with a strong safety profile and minimal side effects, as demonstrated in a study published in the Journal of Cosmetic Dermatology in 2020 5.